Nuclear Medicine Radioisotopes Market Analysis and Forecast by Rapid Growth Rate 2020 Value Share Analysis by Regions, Industry Size, Key Insights till 2024

Nuclear Medicine Radioisotopes

The “Nuclear Medicine Radioisotopes Market” report 2020 covers all the significant developments which are recently being adopted across the global market. The prime objective of the Nuclear Medicine Radioisotopes market report is to provides an in-depth analysis of all market dynamics including drivers and restraints, and trends, and opportunities. The Nuclear Medicine Radioisotopes market report covers both the demand and supply aspects of the market. The report also highlighted the future trends in the Nuclear Medicine Radioisotopes market that will impact the demand during the forecast period.

Scope of the Report:

As per the , medical radioisotopes are defined as safe radioactive substances that are primarily used in the diagnosis of medical conditions. These radioisotopes, used in a diagnosis, emit gamma rays of energy that are sufficient to escape from the body. The rays also have a short half-life, which is apt, since the rays can decay as soon as the imaging is completed.

Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999554

Market Overview:

  • Increasing cases of cancer and cardiac ailments are the major drivers for the nuclear medicines radioisotopes market. Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics. They meet the statutory definition of drugs under Section 1861(t) of the Social Security Act because they either are included in the various drug compendia or recognized by hospital medical staff as drugs. Historically, nuclear medicine has been well established as a therapeutic modality for thyroid cancer, Graves’ disease, hyperthyroidism, and bone pain palliation, associated with skeletal metastasis. Hence, the broadening applications of radioisotopes are expected to propel market growth.

    Some of the Top Key Players of Nuclear Medicine Radioisotopes Market Report Are:

  • Agfa
  • Gevaert Group
  • Cardiarc Ltd
  • Digirad Corporation
  • CMR Naviscan (Gamma Medica Inc.)
  • GE Healthcare
  • Positron Corp.
  • Segami Corporation
  • Siemens Healthcare GmBH
  • Nordion (Canada) Inc.
  • NTP Radioisotopes SOC Ltd
  • Bracco S.p.A
  • Cardinal Health Inc.
  • Curium

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    For More Information or Query or Customization Before Buying, Visit athttps://www.industryresearch.co/enquiry/pre-order-enquiry/13999554

    Key Market Trends:

    Oncology Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

    Radiotherapy can be used to treat various medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. PET, which is a precise technique, uses isotopes produced in a cyclotron. It is highly used for a clinical role in oncology, with fluorine-18 as the tracer, and is proven to be the most accurate non-invasive method of detecting and evaluating most cancers. A new field for cancer treatment is targeted alpha therapy (TAT) or alpha radio-immunotherapy, especially for the control of dispersed cancers. Nuclear medicine is proven effective in oncology in several roles, spanning the course of the disease, including the characterization of a mass, staging, restaging, and monitoring of therapeutic response. Hence, owing to these associated factors, the oncology segment is expected to exhibit the fastest growth rate.

    North America captured the Largest Market Share and is Expected to Retain its Dominance

    North America captured the largest market share in the nuclear medicine radioisotopes market. The United States was the largest contributor to the revenue of North America, and is expected to retain its dominance owing to the higher procedural volume and increasing adoption of the nuclear medicine isotopes for various therapeutic applications. Bone scintigraphy is the next most common nuclear medicine procedure performed in the United States, but it represents only 17% of procedures. The volume of PET procedures in the United States is approximately 1.5 million per year. Oncology accounts for more than 90% of the PET and PET/CT procedures performed, whereas cardiology and neurology account for about 4% each. Canada is the largest producer of Technetium-99m. Due to the use of Tc-99m in radiopharmaceuticals, the market is expected to grow at a tremendous rate in Canada. 80% of the nuclear medicine market is driven by Tc-99m in various diagnostic procedures and treatments. Considering these factors associated with the United States and Canada, the North American market is expected to experience accelerated growth rates and market dominance.

    The Report Covers:

    • Comprehensive research methodology of Nuclear Medicine Radioisotopes market
    • In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
    • Analysis of regional regulations and other government policies impacting the global sleep aid market
    • Insights about market determinants which are stimulating the global Nuclear Medicine Radioisotopes market
    • Detailed and extensive market segments with regional distribution of forecasted revenues
    • Extensive profiles and recent developments of market players Companies Mentioned

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/13999554

    Detailed TOC of Nuclear Medicine Radioisotopes Market Report 2020-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Incidences of Cancer and Cardiac Disorders
    4.2.2 Widening Applications of Nuclear Medicine
    4.2.3 Increasing SPECT and PET Applications
    4.2.4 Increasing Patient Awareness for Healthcare
    4.3 Market Restraints
    4.3.1 Reimbursement Complications
    4.3.2 Regulatory Issues
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Type of Radioisotopes
    5.1.1 Technetium-99m (Tc-99m)
    5.1.2 Thallium-201 (Tl-201)
    5.1.3 Iodine (I-123)
    5.1.4 Fluorine-18
    5.1.5 Rubidium-82 (Rb-82)
    5.1.6 Iodine-131 (I-131)
    5.1.7 Lutetium-177 (Lu-177)
    5.1.8 Radium-223 (Ra-223) & Alpharadin
    5.1.9 Actinium-225 (Ac-225)
    5.1.10 Others
    5.2 Application
    5.2.1 Oncology
    5.2.2 Cardiology
    5.2.3 Lymphoma
    5.2.4 Thyroid
    5.2.5 Neurology
    5.2.6 Other Applications
    5.3 Geography
    5.3.1 North America
    5.3.1.1 United States
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 United Kingdom
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Rest of the World

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Agfa-Gevaert Group
    6.1.2 Cardiarc Ltd
    6.1.3 Digirad Corporation
    6.1.4 CMR Naviscan (Gamma Medica Inc.)
    6.1.5 GE Healthcare
    6.1.6 Positron Corp.
    6.1.7 Segami Corporation
    6.1.8 Siemens Healthcare GmBH
    6.1.9 Nordion (Canada) Inc.
    6.1.10 NTP Radioisotopes SOC Ltd
    6.1.11 Bracco S.p.A
    6.1.12 Cardinal Health Inc.
    6.1.13 Curium

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Smart Radiator Valves Market Share Value Analysis with Key Technologies 2020 Market Dynamics of Key Players, Global Opportunities, Demand Status Forecast till 2026

    Anesthesia Delivery Systems Market Size, Share, Top Manufacturers 2020 Future Growth Rate, Industry Trends, Business Strategy, Demand Status by 2026 With COVID-19 Analysis

    Cellular Network Subscription Market New Report 2020 to 2023 Global Industry Research by Forecast, Top Key Players, Demand Status, Business Strategy, and Future Trends

    Calcium Sulphate Raised Access Floor Market 2020: Global Industry Overview by Top Key Players Size, Share, Future Growth, Development, Revenue, and Growth Factors up to 2025

    Plastic Raschig Rings Market 2020 – Global Industry Size Estimation, Research Update, Future Scope, Revenue, Pricing Trends, Growth Opportunity, Regional Outlook and Forecast to 2025

    Concrete and Cement Market Size Research Analysis 2020 Comprehensive Insights of Manufacturers, Global Opportunities, Business Updates by Share, Growth Factors till 2024